Back to Trades
Total Value
$70.0K
Filing Date
May 4, 2026
1 transactions
Trade Summary
On May 1, 2026, DEBBANE RAYMOND, Director, reported $70.0K of LEXICON PHARMACEUTICALS, INC. (LXRX) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $1.61. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- LEXICON PHARMACEUTICALS, INC.
- Ticker Symbol
- LXRX
- CIK
- 0001062822
Insider Information
- Name
- DEBBANE RAYMOND
- Role
- Director
- Location
- THE WOODLANDS, TX
Filing Details
- Filing Date
- May 4, 2026
- Transaction Date
- May 1, 2026
- Accession Number
- 0001062822-26-000067
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| May 1, 2026 | LXRX derivative | 35,714 | — | Grant/Award | — |
| May 1, 2026 | LXRX derivative | 43,478 | $1.61 | Grant/Award | $70.0K |
Want live alerts when DEBBANE RAYMOND trades again?
Download Insider Trades to track LXRX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
- (F2)Each restricted stock unit represents a contingent right to receive one share of common stock.
- (F3)Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.